Literature DB >> 17525716

Hypothesis--haptoglobin genotype and diabetic nephropathy.

Farid M Nakhoul1, Rachel Miller-Lotan, Huda Awaad, Rabea Asleh, Andrew P Levy.   

Abstract

Vascular complications cause serious morbidity in patients with diabetes mellitus. Three such complications are nephropathy, retinopathy and accelerated atherosclerotic cardiovascular disease. There is currently scant evidence of a genetic marker that predicts which patients will have vascular complications. Oxidative stress has an important role in the development of diabetic vascular complications. Haptoglobin (Hp) is a hemoglobin-binding protein that has a major role in protecting against heme-driven oxidative stress. There are two common alleles for Hp (1 and 2) and, therefore, three common Hp genotypes: Hp 1-1, Hp 2-1, and Hp 2-2. The antioxidant protection provided by Hp is genotype-dependent; the protein encoded by Hp 1-1 provides superior antioxidant protection compared with that encoded by Hp 2-2. We have shown that diabetic individuals with Hp 2-2 are more likely to develop nephropathy, retinopathy, and cardiovascular disease than those with the Hp 2-1 or Hp 1-1 genotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525716     DOI: 10.1038/ncpneph0467

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  15 in total

1.  Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats.

Authors:  Annie J Kruger; Chaoxing Yang; Sun W Tam; Douglas Hinerfeld; James E Evans; Karin M Green; John Leszyk; Kejian Yang; Dennis L Guberski; John P Mordes; Dale L Greiner; Aldo A Rossini; Rita Bortell
Journal:  Exp Biol Med (Maywood)       Date:  2010-11

2.  The acute phase protein haptoglobin regulates host immunity.

Authors:  Kristin M Huntoon; Yanping Wang; Cheryl A Eppolito; Karen W Barbour; Franklin G Berger; Protul A Shrikant; Heinz Baumann
Journal:  J Leukoc Biol       Date:  2008-04-24       Impact factor: 4.962

3.  Plasma biomarkers of mouse aging.

Authors:  Juan Ding; John J Kopchick
Journal:  Age (Dordr)       Date:  2010-09-15

Review 4.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

5.  Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.

Authors:  Thomas A VanderJagt; Monica H Neugebauer; Marilee Morgan; Donald W Bowden; Vallabh O Shah
Journal:  World J Diabetes       Date:  2015-08-10

6.  Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury "stress response".

Authors:  Richard A Zager; Anitha Vijayan; Ali C M Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-09

7.  Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.

Authors:  Mohamed Al-Shabrawey; Sylvia Smith
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

8.  Haptoglobin is required to prevent oxidative stress and muscle atrophy.

Authors:  Enrico Bertaggia; Gaia Scabia; Stefania Dalise; Francesca Lo Verso; Ferruccio Santini; Paolo Vitti; Carmelo Chisari; Marco Sandri; Margherita Maffei
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).

Authors:  Margherita Maffei; Marcella Funicello; Teresa Vottari; Olimpia Gamucci; Mario Costa; Simonetta Lisi; Alessandro Viegi; Osele Ciampi; Giuseppe Bardi; Paolo Vitti; Aldo Pinchera; Ferruccio Santini
Journal:  BMC Biol       Date:  2009-12-17       Impact factor: 7.431

10.  Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis.

Authors:  Stefania Mondello; Firas H Kobeissy; Yehia Mechref; Jingfu Zhao; Samer El Hayek; Kazem Zibara; Monica Moresco; Giuseppe Plazzi; Filomena I I Cosentino; Raffaele Ferri
Journal:  Nat Sci Sleep       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.